Catalyst Wire Dossier Catalyst Wire Dossier

HYALOBARRIER GEL ENDO

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HYALOBARRIER GEL ENDO, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant [NA]

See pricing